Literature DB >> 23417277

The quality of cardiovascular disease care for adolescents with kidney disease: a Midwest Pediatric Nephrology Consortium study.

David K Hooper1, Jason C Williams, Adam C Carle, Sandra Amaral, Deepa H Chand, Maria E Ferris, Hiren P Patel, Christoph Licht, Gina-Marie Barletta, Veronica Zitterman, Mark Mitsnefes, Uptal D Patel.   

Abstract

BACKGROUND: Cardiovascular disease is the leading cause of increased mortality for adolescents with advanced kidney disease. The quality of preventive cardiovascular care may impact long-term outcomes for these patients.
METHODS: We reviewed the records of 196 consecutive adolescents from eight centers with pre-dialysis chronic kidney disease, on dialysis or with a kidney transplant, who transferred to adult-focused providers. We compared cardiovascular risk assessment and therapy within and across centers. Predictors of care were assessed using multilevel models.
RESULTS: Overall, 58 % (range 44-86 %; p = 0.08 for variance) of five recommended cardiovascular risk assessments were documented. Recommended therapy for six modifiable cardiovascular risk factors was documented 57 % (26-76 %; p = 0.09) of the time. Of these patients, 30 % (n = 59) were reported to go through formal transition which was independently associated with a 21 % increase in composite cardiovascular risk assessment (p < 0.001). Transfer after 2006 and kidney transplant status were also associated with increased cardiovascular risk assessment (p < 0.01 and p = 0.045, respectively).
CONCLUSIONS: Adolescents with kidney disease receive suboptimal preventive cardiovascular care, that may contribute to their high risk of future cardiovascular mortality. A great opportunity exists to improve outcomes for children with kidney disease by improving the reliability of preventive care that may include formal transition programs.

Entities:  

Mesh:

Year:  2013        PMID: 23417277      PMCID: PMC3637925          DOI: 10.1007/s00467-013-2419-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  35 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-04       Impact factor: 8.860

3.  A consensus statement on health care transitions for young adults with special health care needs.

Authors: 
Journal:  Pediatrics       Date:  2002-12       Impact factor: 7.124

4.  Transition to adult health care for adolescents and young adults with chronic conditions: position paper of the Society for Adolescent Medicine.

Authors:  David S Rosen; Robert W Blum; Maria Britto; Susan M Sawyer; David M Siegel
Journal:  J Adolesc Health       Date:  2003-10       Impact factor: 5.012

5.  Effects of body size and body composition on survival in hemodialysis patients.

Authors:  Srinivasan Beddhu; Lisa M Pappas; Nirupama Ramkumar; Matthew Samore
Journal:  J Am Soc Nephrol       Date:  2003-09       Impact factor: 10.121

6.  K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2004-05       Impact factor: 8.860

7.  Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report.

Authors: 
Journal:  Pediatrics       Date:  2011-11-14       Impact factor: 7.124

8.  Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative.

Authors:  B Kasiske; F G Cosio; J Beto; K Bolton; B M Chavers; R Grimm; A Levin; B Masri; R Parekh; C Wanner; D C Wheeler; P W F Wilson
Journal:  Am J Transplant       Date:  2004       Impact factor: 8.086

9.  Long-term survival of children with end-stage renal disease.

Authors:  Stephen P McDonald; Jonathan C Craig
Journal:  N Engl J Med       Date:  2004-06-24       Impact factor: 91.245

10.  Abnormal cardiac function in children after renal transplantation.

Authors:  Mark M Mitsnefes; Thomas R Kimball; William L Border; Sandra A Witt; Betty J Glascock; Philip R Khoury; Stephen R Daniels
Journal:  Am J Kidney Dis       Date:  2004-04       Impact factor: 8.860

View more
  11 in total

Review 1.  A systems-based approach to managing blood pressure in children following kidney transplantation.

Authors:  David K Hooper; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2015-10-19       Impact factor: 3.714

2.  Outcomes after pediatric kidney transplantation improving: how can we do even better?

Authors:  Uptal D Patel
Journal:  Pediatrics       Date:  2014-03-10       Impact factor: 7.124

Review 3.  Adherence in pediatric kidney transplant recipients: solutions for the system.

Authors:  Elizabeth A Steinberg; Mary Moss; Cindy L Buchanan; Jens Goebel
Journal:  Pediatr Nephrol       Date:  2017-03-27       Impact factor: 3.714

4.  Secular Trends in Survival Outcomes of Kidney Transplantation for Children: Is the Future Bright Enough?

Authors:  Sandra Amaral
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-19       Impact factor: 8.237

5.  Physical activity and screen time in adolescents in the chronic kidney disease in children (CKiD) cohort.

Authors:  Stephanie L Clark; Michelle R Denburg; Susan L Furth
Journal:  Pediatr Nephrol       Date:  2015-12-18       Impact factor: 3.714

6.  One-year mortality rates in US children with end-stage renal disease.

Authors:  Blanche M Chavers; Julia T Molony; Craig A Solid; Michelle N Rheault; Allan J Collins
Journal:  Am J Nephrol       Date:  2015-03-07       Impact factor: 3.754

Review 7.  Long-Term Outcomes of Kidney Transplantation in Children.

Authors:  Pamela D Winterberg; Rouba Garro
Journal:  Pediatr Clin North Am       Date:  2019-02       Impact factor: 3.278

8.  Prevalence and predictors of aortic dilation as a novel cardiovascular complication in children with end-stage renal disease.

Authors:  Ahmad Kaddourah; Susan Uthup; Peace Madueme; Matthew O'Rourke; David K Hooper; Michael D Taylor; Steven D Colan; John L Jefferies; Marepalli B Rao; Jens Goebel
Journal:  Clin Nephrol       Date:  2015-05       Impact factor: 0.975

9.  What has changed in the prevalence of hypertension in dialyzed children during the last decade?

Authors:  Marcin Tkaczyk; Małgorzata Stańczyk; Monika Miklaszewska; Katarzyna Zachwieja; Ryszard Wierciński; Roman Stankiewicz; Agnieszka Firszt-Adamczyk; Jacek Zachwieja; Halina Borzęcka; Ilona Zagożdżon; Beata Leszczyńska; Anna Medyńska; Piotr Adamczyk; Maria Szczepańska; Wojciech Fendler
Journal:  Ren Fail       Date:  2016-11-24       Impact factor: 2.606

Review 10.  Management of dyslipidemia in pediatric renal transplant recipients.

Authors:  Margret E Bock; Leslie Wall; Carly Dobrec; Mary Chandran; Jens Goebel
Journal:  Pediatr Nephrol       Date:  2020-01-02       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.